Clinical trial
Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS)…
NCT00245297 · Recoly N.V., Industry · Completed
Key facts
| NCT number | NCT00245297 |
|---|---|
| Title | Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. |
| Official title | A Patient-Blinded, Randomized, Comparative, Multicenter, Crossover, (Liposome) Dose Finding Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. |
| Lead sponsor | Recoly N.V., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Haemophilia A |
| Intervention type | Drug |
| Interventions | Kogenate FS, reconstituted in a suspension of liposomes |
| Enrollment | 16 |
| Start date | Oct 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Oct 27, 2005 |
| Last update posted | Oct 16, 2007 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: